Allergy Asthma Dermatology is categorized under Clinics in Corpus Christi, TX .
Allergy Asthma Dermatology was established in 0, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Robert Burkenbine, Manager at the company’s single location by writing to 2502 Morgan Avenue, Corpus Christi, Texas TX 78405 or by phoning (361) 888-6782. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Allergy Asthma Dermatology |
| Contact Person: | Robert Burkenbine, Manager |
| Address: | 2502 Morgan Avenue, Corpus Christi, Texas 78405 |
| Phone Number: | (361) 888-6782 |
| Website Address: | asthmaandallergy.com |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Clinics |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Allergy Asthma Dermatology was started in 0 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Robert Burkenbine, Manager for inquiries that concern Allergy Asthma Dermatology by calling the company number (361) 888-6782, as your correspondence is most welcome. Additionally, the physical location of the single location of Allergy Asthma Dermatology can be found at the coordinates 27.7781,-97.41667 as well as the street address 2502 Morgan Avenue in Corpus Christi, Texas 78405.
For its online presence, you may visit Allergy Asthma Dermatology’s website at asthmaandallergy.com and engage with its social media outlets through on Twitter and on Facebook.